Intra Cellular Therapies reported $10.4M in Trade Creditors for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US USD 12.75M 2.74M
Aptinyx Inc APTX:US USD 474K 1.63M
Biogen BIIB:US USD 491.5M 108.3M
Cytokinetics CYTK:US USD 25.61M 11.18M
Esperion Therapeutics ESPR:US USD 23.04M 4.46M
Halozyme Therapeutics HALO:US USD 17.69M 473K
Intra Cellular Therapies ITCI:US USD 10.4M 3.82M
Marinus Pharmaceuticals MRNS:US USD 4.46M 2.84M
Minerva Neurosciences NERV:US USD 970K 437K
Nektar Therapeutics NKTR:US USD 12.98M 7.65M
Novartis NVS:US USD 5.15B 453M
Prothena PRTA:US USD 9.27M 518K
Supernus Pharmaceuticals SUPN:US USD 10.54M 5.47M
Vanda Pharmaceuticals VNDA:US USD 4.98M 606K